I-Mab ADR (IMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMAB | AMGN | VRTX | REGN | GSK |
| Company | I-Mab ADR | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.7500 | 315.28 | 442.00 | 969.27 | 44.85 |
| High | 1.7700 | 315.28 | 446.10 | 982.77 | 45.09 |
| Low | 1.7400 | 310.37 | 440.35 | 966.00 | 44.74 |
| Last | 1.7500 | 312.47 | 445.21 | 982.29 | 44.98 |
| Change | -0.0200 | -2.25 | +4.57 | +14.31 | +0.10 |
| % Change | -1.13% | -0.71% | +1.04% | +1.48% | +0.22% |
| Volume | 271,900 | 1,974,200 | 1,382,400 | 386,500 | 1,882,900 |
| 20-Day Average Volume | 157,310 | 2,910,960 | 1,122,380 | 455,815 | 3,491,155 |
| Previous Close | 1.7700 | 314.72 | 440.64 | 967.98 | 44.88 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.7935 | 293.57 | 412.42 | 939.27 | 43.25 |
| 20-Day Raw Stochastic | 12.33% | 82.19% | 98.36% | 94.14% | 84.16% |
| 20-Day Relative Strength | 45.18% | 63.74% | 72.10% | 61.09% | 66.00% |
| Weighted Alpha | -45.31 | +38.84 | +33.13 | +30.85 | +31.55 |
| Today's Opinion | 8% Sell | 72% Buy | 72% Buy | 72% Buy | 100% Buy |
| Previous Opinion | Hold | 72% Buy | 72% Buy | 72% Buy | 100% Buy |
| Last Month's Opinion | 8% Buy | 56% Sell | 8% Buy | 24% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.69% since 05/10/24 | +0.75% since 05/10/24 | +5.31% since 05/10/24 | +0.87% since 05/10/24 | -0.20% since 05/10/24 |
| Low | 1.7275 on 05/16/24 | 307.06 on 05/13/24 | 422.44 on 05/14/24 | 966.00 on 05/17/24 | 44.74 on 05/17/24 |
| High | 1.9100 on 05/15/24 | 321.44 on 05/15/24 | 446.10 on 05/17/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
| 1-Month | |||||
| %Chg | -3.31% since 04/17/24 | +18.33% since 04/17/24 | +13.26% since 04/17/24 | +9.00% since 04/17/24 | +13.59% since 04/17/24 |
| Low | 1.7275 on 05/16/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 1.9100 on 05/15/24 | 322.60 on 05/03/24 | 446.10 on 05/17/24 | 988.96 on 05/15/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | +2.34% since 02/16/24 | +10.14% since 02/16/24 | +5.45% since 02/16/24 | +3.61% since 02/16/24 | +7.25% since 02/16/24 |
| Low | 1.5100 on 02/23/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 1.9700 on 03/26/24 | 322.60 on 05/03/24 | 446.10 on 05/17/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | +6.06% since 11/17/23 | +17.74% since 11/17/23 | +27.02% since 11/17/23 | +22.41% since 11/17/23 | +27.78% since 11/17/23 |
| Low | 1.3605 on 12/18/23 | 260.52 on 11/21/23 | 346.29 on 11/28/23 | 792.57 on 11/28/23 | 34.97 on 11/20/23 |
| High | 2.5362 on 01/03/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 143,163 | 168,826,816 | 113,708,480 | 106,657,832 | 93,011,112 |
| Shares Outstanding, K | 80,883 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 3,890,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -206,440,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 1,542,668,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | 1,041,550,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | 1.10 | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 03/29/24 | 05/02/24 | 05/06/24 | 05/02/24 | 05/01/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.13 | 29.05 | 26.36 | 11.31 |